Why is P & G Health Ltd falling/rising?

As of 12-Sep, Procter & Gamble Health Ltd's stock price is currently at 6,245.35, reflecting a decrease of 115.15 points, or 1.81%. The stock has underperformed its sector by 2.1% today, with an intraday low of Rs 6,226.55. Over the past week, the stock has declined by 3.84%, while it has shown a modest decline of 1.54% over the past month. Despite a strong year-to-date performance of 19.41% and a 17.87% increase over the past year, the recent price movement is influenced by falling investor participation, as evidenced by a 43.33% drop in delivery volume compared to the five-day average. While the company boasts high management efficiency and positive financial results over the last four quarters, concerns about its long-term growth potential and high valuation metrics may be contributing to the current downward trend.
In the broader market context, the Sensex has increased by 1.48% over the past week, contrasting with the stock's decline, indicating that the stock is not keeping pace with the overall market. The company's long-term growth has been relatively poor, with net sales growing at an annual rate of only 7.39% over the last five years. Although the stock has shown strong performance in the long term and has high institutional holdings, the expensive valuation and lower-than-expected growth rates may be causing investors to reassess their positions, leading to the current decline in stock price.